News
06-07-2010, 07:22 AM
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
More... (http://www.news-medical.net/news/20100607/Promising-clinical-data-on-CDX-011-in-metastatic-melanoma-presented-at-ASCO-Annual-Meeting.aspx)
More... (http://www.news-medical.net/news/20100607/Promising-clinical-data-on-CDX-011-in-metastatic-melanoma-presented-at-ASCO-Annual-Meeting.aspx)